BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jürchott K, Schulz AR, Bozzetti C, Pohlmann D, Stervbo U, Warth S, Mälzer JN, Waldner J, Schweiger B, Olek S, Grützkau A, Babel N, Thiel A, Neumann AU. Highly Predictive Model for a Protective Immune Response to the A(H1N1)pdm2009 Influenza Strain after Seasonal Vaccination. PLoS One 2016;11:e0150812. [PMID: 26954292 DOI: 10.1371/journal.pone.0150812] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 de Armas LR, Pallikkuth S, George V, Rinaldi S, Pahwa R, Arheart KL, Pahwa S. Reevaluation of immune activation in the era of cART and an aging HIV-infected population. JCI Insight 2017;2:e95726. [DOI: 10.1172/jci.insight.95726] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
2 Meyer-Arndt L, Schwarz T, Loyal L, Henze L, Kruse B, Dingeldey M, Gürcan K, Uyar-Aydin Z, Müller MA, Drosten C, Paul F, Sander LE, Demuth I, Lauster R, Giesecke-Thiel C, Braun J, Corman VM, Thiel A. Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly. J Immunol 2022;208:1001-5. [PMID: 35121642 DOI: 10.4049/jimmunol.2100990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tsang JS, Dobaño C, VanDamme P, Moncunill G, Marchant A, Othman RB, Sadarangani M, Koff WC, Kollmann TR. Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome? Trends Immunol 2020;41:457-65. [PMID: 32340868 DOI: 10.1016/j.it.2020.04.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
4 Gianchecchi E, Torelli A, Montomoli E. The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity. Hum Vaccin Immunother 2019;15:1021-30. [PMID: 30614754 DOI: 10.1080/21645515.2019.1565269] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
5 Stervbo U, Pohlmann D, Baron U, Bozzetti C, Jürchott K, Mälzer JN, Nienen M, Olek S, Roch T, Schulz AR, Warth S, Neumann A, Thiel A, Grützkau A, Babel N. Age dependent differences in the kinetics of γδ T cells after influenza vaccination. PLoS One 2017;12:e0181161. [PMID: 28700738 DOI: 10.1371/journal.pone.0181161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
6 Stanisic DI, McCall MBB. Correlates of malaria vaccine efficacy. Expert Rev Vaccines 2021;20:143-61. [PMID: 33499692 DOI: 10.1080/14760584.2021.1882309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Skarlupka AL, Handel A, Ross TM. Influenza hemagglutinin antigenic distance measures capture trends in HAI differences and infection outcomes, but are not suitable predictive tools. Vaccine 2020;38:5822-30. [PMID: 32682618 DOI: 10.1016/j.vaccine.2020.06.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Dauner A, Agrawal P, Salvatico J, Tapia T, Dhir V, Shaik SF, Drake DR 3rd, Byers AM. The in vitro MIMIC® platform reflects age-associated changes in immunological responses after influenza vaccination. Vaccine 2017;35:5487-94. [PMID: 28413134 DOI: 10.1016/j.vaccine.2017.03.099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
9 Leibinger EA, Pauler G, Benedek N, Berki T, Jankovics I, McNally R, Ottóffy G. Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy. Front Immunol 2021;12:690940. [PMID: 34267757 DOI: 10.3389/fimmu.2021.690940] [Reference Citation Analysis]